Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system
- PMID: 28700670
- PMCID: PMC5507302
- DOI: 10.1371/journal.pone.0180991
Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system
Abstract
Accumulating evidence suggests that dietary taurine (2-aminoethanesulfonic acid) exerts beneficial anti-inflammatory effects in the large intestine. In this study, we investigated the possible impact of taurine on human colonic microbiota using our single-batch fermentation system (Kobe University Human Intestinal Microbiota Model; KUHIMM). Fecal samples from eight humans were individually cultivated with and without taurine in the KUHIMM. The results showed that taurine remained largely undegraded after 30 h of culturing in the absence of oxygen, although some 83% of the taurine was degraded after 30 h of culturing under aerobic conditions. Diversity in bacterial species in the cultures was analyzed by 16S rRNA gene sequencing, revealing that taurine caused no significant change in the diversity of the microbiota; both operational taxonomic unit and Shannon-Wiener index of the cultures were comparable to those of the respective source fecal samples. In addition, principal coordinate analysis indicated that taurine did not alter the composition of bacterial species, since the 16S rRNA gene profile of bacterial species in the original fecal sample was maintained in each of the cultures with and without taurine. Furthermore, metabolomic analysis revealed that taurine did not affect the composition of short-chain fatty acids produced in the cultures. These results, under these controlled but artificial conditions, suggested that the beneficial anti-inflammatory effects of dietary taurine in the large intestine are independent of the intestinal microbiota. We infer that dietary taurine may act directly in the large intestine to exert anti-inflammatory effects.
Conflict of interest statement
Figures
References
-
- Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72: 101–163. - PubMed
-
- Chen W, Guo JX, Chang P. The effect of taurine on cholesterol metabolism. Mol Nutr Food Res. 2012;56: 681–690. doi: 10.1002/mnfr.201100799 - DOI - PubMed
-
- Cuttitta CM, Guariglia SR, Idrissi AE, L’amoreaux WJ. Taurine’s effects on the neuroendocrine functions of pancreatic β cells. Adv Exp Med Biol. 2013;775: 299–310. doi: 10.1007/978-1-4614-6130-2_25 - DOI - PubMed
-
- Huang C, Guo Y, Yuan J. Dietary taurine impairs intestinal growth and mucosal structure of broiler chickens by increasing toxic bile acid concentrations in the intestine. Poult Sci. 2014;93: 1475–1483. doi: 10.3382/ps.2013-03533 - DOI - PubMed
-
- Maia AR, Batista TM, Victorio JA, Clerici SP, Delbin MA. Taurine supplementation reduces blood pressure and prevents endothelial dysfunction and oxidative stress in post-weaning protein-restricted rats. PLoS One. 2014;9: e105851 doi: 10.1371/journal.pone.0105851 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
